Voluson Expert 22 represents a major step forward in ultrasound innovation from a market leader in Women’s Health Ultrasound Next-generation architecture behind Voluson Expert 22 includes Voluson ...

GE HealthCare said in a statement Thursday it will use a $44 million contract with a federal preparedness agency to develop ultrasound technology with artificial intelligence applications that can ...

GE HealthCare has landed a $44 million grant from the Bill & Melinda Gates Foundation to develop ultrasound technology for developing countries in need of better ways to provide lung and obstetric ...

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced its Venue Family point-of-care ultrasound systems will now feature Caption Guidance, artificial intelligence (AI)-driven ...

GE HealthCare has entered into an agreement to acquire Intelligent Ultrasound's clinical artificial intelligence software business for $51 million. Intelligent Ultrasound specializes in integrated ...

Integrated artificial intelligence (AI) and advanced tools improve image quality and exam speed to help providers make accurate diagnoses and tailor precision care for women Latest Voluson Signature ...

GE HealthCare says it plans to develop an AI-assisted ultrasound imaging tool that is so simple, that even healthcare providers without specialized training will be able to use it. The research and ...

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the updated portfolio of Voluson™ ...

A little more than a year after acquiring the artificial intelligence developer Caption Health, GE HealthCare has brought its cardiac ultrasound coaching programs to its hand-held scanner. Caption’s ...

GE HealthCare this past week said it will acquire the clinical artificial intelligence business of Intelligent Ultrasound Group. The price for the software buy is about $51 million, the companies said ...

GE HealthCare (NASDAQ:GEHC) announced a partnership with Novo Nordisk (NVO) on Thursday to jointly develop an ultrasound-based technology to treat type 2 diabetes, obesity, and other chronic ...

Vaso Corporation137 Commercial StreetPlainview, New York 11803Tel: (516) 997-4600 Fax: (516) 997-2299Investor Contact:Jonathan NewtonInvestor ...